Details for New Drug Application (NDA): 070425
✉ Email this page to a colleague
NDA 070425 describes Q-PAM, which is a drug marketed by Quantum Pharmics and is included in six NDAs. Additional details are available on the Q-PAM profile page.
The generic ingredient in Q-PAM is diazepam. There are eight drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the diazepam profile page.
The generic ingredient in Q-PAM is diazepam. There are eight drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the diazepam profile page.
Summary for 070425
| Tradename: | Q-PAM |
| Applicant: | Quantum Pharmics |
| Ingredient: | diazepam |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 070425
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Dec 12, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
